In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Kura Oncology Inc’s stock clocked out at $17.77, down -0.39% from its previous closing price of $17.84. In other words, the price has decreased by -$0.39 from its previous closing price. On the day, 0.55 million shares were traded. KURA stock price reached its highest trading level at $18.26 during the session, while it also had its lowest trading level at $17.62.
Ratios:
To gain a deeper understanding of KURA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.94 and its Current Ratio is at 14.94. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $27.
On October 14, 2024, Stifel Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $26 to $19.
On December 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $26.Mizuho initiated its Buy rating on December 22, 2023, with a $26 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 20 ’24 when Bair Teresa Brophy sold 2,615 shares for $22.15 per share. The transaction valued at 57,916 led to the insider holds 68,979 shares of the business.
DOYLE THOMAS JAMES sold 2,318 shares of KURA for $41,262 on Jan 29 ’24. The SVP, Finance & Accounting now owns 48,093 shares after completing the transaction at $17.80 per share. On Jan 29 ’24, another insider, Bair Teresa Brophy, who serves as the Chief Legal Officer of the company, sold 2,053 shares for $17.80 each. As a result, the insider received 36,544 and left with 68,979 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KURA now has a Market Capitalization of 1361795072 and an Enterprise Value of 887009024.
Stock Price History:
Over the past 52 weeks, KURA has reached a high of $24.17, while it has fallen to a 52-week low of $8.17. The 50-Day Moving Average of the stock is -5.65%, while the 200-Day Moving Average is calculated to be -11.90%.
Shares Statistics:
It appears that KURA traded 556.23K shares on average per day over the past three months and 794440 shares per day over the past ten days. A total of 74.35M shares are outstanding, with a floating share count of 64.93M. Insiders hold about 15.28% of the company’s shares, while institutions hold 90.93% stake in the company. Shares short for KURA as of 1728950400 were 9292585 with a Short Ratio of 16.71, compared to 1726185600 on 10754263. Therefore, it implies a Short% of Shares Outstanding of 9292585 and a Short% of Float of 12.25.
